# The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker

> **NCT03245996** · PHASE4 · COMPLETED · sponsor: **Tartu University Hospital** · enrollment: 27 (actual)

## Conditions studied

- Aortic Blood Pressure

## Interventions

- **DEVICE:** AAI 40 bpm
- **DEVICE:** AAI 60 bpm
- **DEVICE:** AAI 90 bpm
- **DRUG:** Atenolol Pill
- **DRUG:** Nebivolol Pill
- **DRUG:** Ivabradine Pill

## Key facts

- **NCT ID:** NCT03245996
- **Lead sponsor:** Tartu University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03245996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03245996, "The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03245996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*